Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in US
Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar's orphan indication products, resulting in non-dilutive funding for Jaguar
Read More
Neutral publishes the results of a successful, first-of-its-kind 3-hour fire test for a hybrid mass timber building assembly with standard connectors for free use by industry practitioners. These results help solidify the future of building with mass timber and contribute to a larger trend toward sustainable construction.
Read More
Clearout raises the bar on lead quality with Form Guard - a next-generation solution that stops fake signups, filters out spam, and validates every form field in real time, empowering marketers and sales teams to capture only authentic, conversion-ready leads.
Read More
Prodify unites digital assets and product data in one powerful platform, giving marketing and sales teams everything they need to centralize, visualize, and optimize content with ease.
Read MoreAccelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships
Read MoreEarly revenues and $2.1M SmellTech-as-a-Service order set the stage for large-scale commercialization in 2026
Robotics and industrial deployments expand long-term growth runway beyond healthcare
Read More
A Bold Breakthrough in the Future of Wedding Planning, Pearl Planner's AI Allows Deeply Personalized, Intelligent Wedding Planning That Adapts to Each Couple's Style, Pace and Vision
Read MoreAs announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating MVID patient by up to 27%; abstract describing results accepted for presentation at upcoming North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) 2025 Annual Meeting in Chicago
Read More